163 related articles for article (PubMed ID: 34037007)
21. Hetero Bodipy-dimers as heavy atom-free triplet photosensitizers showing a long-lived triplet excited state for triplet-triplet annihilation upconversion.
Wu W; Cui X; Zhao J
Chem Commun (Camb); 2013 Oct; 49(79):9009-11. PubMed ID: 23969566
[TBL] [Abstract][Full Text] [Related]
22. BODIPY-Based Photosensitizers as Potential Anticancer and Antibacterial Agents: Role of the Positive Charge and the Heavy Atom Effect.
Piskorz J; Porolnik W; Kucinska M; Dlugaszewska J; Murias M; Mielcarek J
ChemMedChem; 2021 Jan; 16(2):399-411. PubMed ID: 32964632
[TBL] [Abstract][Full Text] [Related]
23. Biotin-decorated NIR-absorbing nanosheets for targeted photodynamic cancer therapy.
Perumal D; Golla M; Pillai KS; Raj G; Krishna P K A; Varghese R
Org Biomol Chem; 2021 Mar; 19(12):2804-2810. PubMed ID: 33720265
[TBL] [Abstract][Full Text] [Related]
24. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
25. Triphenylphosphonium-functionalized dimeric BODIPY-based nanoparticles for mitochondria-targeting photodynamic therapy.
Kim C; Mai DK; Lee J; Jo J; Kim S; Badon IW; Lim JM; Kim HJ; Yang J
Nanoscale; 2024 May; 16(19):9462-9475. PubMed ID: 38639449
[TBL] [Abstract][Full Text] [Related]
26. A mitochondrion-targeted BODIPY-Ir(III) conjugate as a photoinduced ROS generator for the oxidative destruction of triple-negative breast cancer cells.
Qiao L; Liu J; Kuang S; Liao X; Kou J; Ji L; Chao H
Dalton Trans; 2021 Oct; 50(40):14332-14341. PubMed ID: 34558567
[TBL] [Abstract][Full Text] [Related]
27. Double pH-sensitive nanotheranostics of polypeptide nanoparticle encapsulated BODIPY with both NIR activated fluorescence and enhanced photodynamic therapy.
Dang H; Cheng Q; Tian Y; Teng C; Xie K; Yan L
J Mater Chem B; 2021 Nov; 9(42):8871-8881. PubMed ID: 34693964
[TBL] [Abstract][Full Text] [Related]
28. Highly efficient near-infrared BODIPY phototherapeutic nanoparticles for cancer treatment.
Zhang Y; Yang Z; Zheng X; Chen L; Xie Z
J Mater Chem B; 2020 Jun; 8(24):5305-5311. PubMed ID: 32453332
[TBL] [Abstract][Full Text] [Related]
29. Targeted Delivery and Site-Specific Activation of β-Cyclodextrin-Conjugated Photosensitizers for Photodynamic Therapy through a Supramolecular Bio-orthogonal Approach.
Xue EY; Shi WJ; Fong WP; Ng DKP
J Med Chem; 2021 Oct; 64(20):15461-15476. PubMed ID: 34662121
[TBL] [Abstract][Full Text] [Related]
30. Phenylthiourea-Conjugated BODIPY as an Efficient Photosensitizer for Tyrosinase-Positive Melanoma-Targeted Photodynamic Therapy.
Jung E; Shim I; An J; Ji MS; Jangili P; Chi SG; Kim JS
ACS Appl Bio Mater; 2021 Mar; 4(3):2120-2127. PubMed ID: 35014340
[TBL] [Abstract][Full Text] [Related]
31. Ubiquinone-BODIPY nanoparticles for tumor redox-responsive fluorescence imaging and photodynamic activity.
Hwang B; Kim TI; Kim H; Jeon S; Choi Y; Kim Y
J Mater Chem B; 2021 Jan; 9(3):824-831. PubMed ID: 33338098
[TBL] [Abstract][Full Text] [Related]
32. A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy.
Zhao X; Yang Y; Yu Y; Guo S; Wang W; Zhu S
Chem Commun (Camb); 2019 Nov; 55(90):13542-13545. PubMed ID: 31647067
[TBL] [Abstract][Full Text] [Related]
33. In vitro photodynamic treatment of cancer cells induced by aza-BODIPYs.
Malacarne MC; Banfi S; Caruso E
Photochem Photobiol Sci; 2020 Jun; 19(6):790-799. PubMed ID: 33856674
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting Radiative Transition-Mediated Multifunctional Polymeric Nanoplatforms for Highly Efficient Tumor Phototherapeutics.
Zhu Y; Chen C; Yang G; Wu Q; Tian J; Hao E; Cao H; Gao Y; Zhang W
ACS Appl Mater Interfaces; 2020 Oct; 12(40):44523-44533. PubMed ID: 32910635
[TBL] [Abstract][Full Text] [Related]
35. Polymeric Encapsulation of Novel Homoleptic Bis(dipyrrinato) Zinc(II) Complexes with Long Lifetimes for Applications as Photodynamic Therapy Photosensitisers.
Karges J; Basu U; Blacque O; Chao H; Gasser G
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14334-14340. PubMed ID: 31386250
[TBL] [Abstract][Full Text] [Related]
36. Femtosecond intersystem crossing to the reactive triplet state of the 2,6-dithiopurine skin cancer photosensitizer.
Ortiz-Rodríguez LA; Hoehn SJ; Acquah C; Abbass N; Waidmann L; Crespo-Hernández CE
Phys Chem Chem Phys; 2021 Nov; 23(44):25048-25055. PubMed ID: 34730146
[TBL] [Abstract][Full Text] [Related]
37. A Local CC2 and TDA-DFT Double Hybrid Study on BODIPY/aza-BODIPY Dimers as Heavy Atom Free Triplet Photosensitizers for Photodynamic Therapy Applications.
Momeni MR; Brown A
J Phys Chem A; 2016 Apr; 120(16):2550-60. PubMed ID: 27035753
[TBL] [Abstract][Full Text] [Related]
38. Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific "Chemo-PDT" Agent Active in Red Light.
Ramu V; Kundu P; Kondaiah P; Chakravarty AR
Inorg Chem; 2021 May; 60(9):6410-6420. PubMed ID: 33843212
[TBL] [Abstract][Full Text] [Related]
39. A photosensitizer with conformational restriction for enhanced photodynamic therapy.
Huang H; Long S; Huang D; Du J; Fan J; Peng X
Chem Commun (Camb); 2021 Sep; 57(72):9100-9103. PubMed ID: 34498645
[TBL] [Abstract][Full Text] [Related]
40. Visible light-absorbing rhenium(I) tricarbonyl complexes as triplet photosensitizers in photooxidation and triplet-triplet annihilation upconversion.
Yi X; Zhao J; Sun J; Guo S; Zhang H
Dalton Trans; 2013 Feb; 42(6):2062-74. PubMed ID: 23178459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
